Cannabis Use Disorder: Insights and Hope with Dr. Meg Haney
Episode Overview
Dr. Meg Haney's groundbreaking research on cannabis withdrawal and treatment options Insights into the biological effects of high-potency THC on the brain Discussions on the challenges of studying cannabis use disorder and mental health Exploration of potential medications for cannabis-related issues Importance of informed decision-making and public awareness on cannabis use
Your cannabis use is not going to help. Yeah, yeah, yeah. One large study, like almost 7 million people in Denmark, showed that if we could target just men between the ages 21 to 30, if we just had that one target and prevented cannabis use disorder in that subsegment of the population, we would have 30% less schizophrenia.
What happens when the highs of cannabis use turn into a daily struggle? Dr. Meg Haney, a neurobiology professor at Columbia University Medical Center, joins Dr. Roneet Lev on 'High Truths on Drugs and Addiction' to explore this question. Dr. Haney shares her extensive research on cannabis use disorder, including the effects of high-potency THC products and the challenges of withdrawal.
She introduces AEF0117, a promising new treatment targeting the CB1 receptor, and discusses its potential to help those battling addiction. The episode also touches on a young man's journey with cannabis use and mental health issues, offering a personal glimpse into the real-world impact of Dr. Haney's work. Whether you're grappling with cannabis use yourself or supporting someone who is, this episode offers valuable insights and hope for the future.